Spin-offs
Valorisation is a key aspect of research at the Faculty of Science. In this context spinoff companies are of importance. Spinoffs are academic companies that transform scientific knowledge into applications for commercial use.
The spinoffs of the Faculty of Science are:
FiriX Therapeutics (2025): Developing a new class of ferroptosis inhibitors
FiriX Therapeutics is developing a new class of ferroptosis inhibitors to treat diseases caused by ischemia-reperfusion injury (IRI). Its lead candidate, FXT-001, is lifesaving in mice and organ saving in pig and human ex vivo transplant settings. By targeting ferroptotic cell death, FiriX aims to deliver first-in-class therapies that prevent IRI-related complications and significantly improve patient outcomes.
Sightera Biosciences (2025): Pioneering clinically correlated drug-response data to power generative drug design
Sightera Biosciences focuses on AI-driven drug discovery, mainly in oncology and regenerative medicine to make drug development faster, more patient-relevant, and more likely to succeed clinically. www.sightera-biosciences.com
Cerryx (2024): Tackling livestock’s biggest challenges with science-driven innovation
Cerryx is harnessing over 15 years of scientific research in the field of microbiology to create “all-in-on” microbial-based animal feed additives that improve animal health and productivity, reduce greenhouse gas emissions and provide farmers with a natural, safe and cost-effective solution.Our collection of proprietary bacteria has been created using advanced scientific know-how and trade secret methods, allowing us to identify and select certain strains that possess unique biological properties. We create novel formulations that unlock superior health benefits.www.cerryx.com
Brailsports (2024): AI platform for optimised sports training
Brailsports, a joint spin-off from the University of Antwerp, imec and University of Ghent, is developing a platform that supports athletes and their coaches to determine optimal training volume and adjust training schedules based on data. Using AI models, the platform accurately estimates fitness and fatigue of the individual athlete, improving performance and reducing the risk of injury.
FAAST (2024): develops innovative sports and exercise simulators
By linking a simple setup (e.g. depth camera or 3D scanner) to an existing indoor trainer (such as Tackx or Wahoo), the cyclist's aerodynamic profile is measured and analysed in real time and transmitted to the indoor trainer in terms of resistance, giving the athlete the effective feeling of cycling outdoors. A cyclist sitting upright can pedal hard, for example, but will not go fast because he encounters too much air resistance. A cyclist who lies flat, on the other hand, will generate less power but still go faster because air resistance is significantly reduced. This effect is strongest at high speeds and is useful for top cyclists and triathletes to determine their fastest position and, if necessary, train their muscle memory in that position.
FAAST therefore offers an accessible alternative and supplement to wind tunnel measurements.
Orbits Oncology (2023): a digital platform using AI to bring cancer patient insights into early drug research
Orbits Oncology is a digital platform that uses AI to bring cancer patient insights into early drug research, by unlocking the most human-like cancer models, called organoids. Biopharma companies using organoids for cancer drug research generate large quantities of microscope image data that are difficult to analyse and interpret. Using proprietary computer vision and data processing algorithms, their digital platform takes this raw image data, performs advanced analysis, and produces reports that provide understandable, clinically relevant insights into the drugs and compounds being investigated.
Their pilots and publications have already demonstrated that this digital solution increases both 1) speed-to-insight, as well as 2) the accuracy of insights compared to conventional solutions. Orbits Oncology’s technology can seamlessly integrate into the existing workflow of their biopharma customers, and using a SAAS-like model, the spin-off will help them identify which drugs to filter out and which drugs to advance towards clinical trials. Their aim is to de-risk cancer research from the lab to the patient, by matching the right therapies with the right patients, and bring drugs more successfully to market.
https://www.orbits-oncology.com/
Atomic 16 (2023): plasma reactors for the production of sulfur oxides from elemental sulphur
Atomic 16 develops plasma reactors for the production of sulfur oxides from elemental sulphur.
More information will follow soon.
Tales of Land (2023): innovative plasma technology to break down harmful PFAS, preventing further spread in the environment
Tales of Land uses innovative plasma technology to break down harmful PFAS, preventing further spread in the environment.
More information will follow soon.
Specifix (2023): 3D planning software for pre-operative, patient-specific fixation of wrist fractures
Specifix, a spin-off of the University of Antwerp and imec, has developed an advanced tool to assist orthopedic surgeons in selecting patient- and wrist-fracture-specific implants. Through the integration of advanced AI technology, Specifix provides 3D solutions that significantly reduce the duration of the surgery while enhancing surgical precision.
Immunespec (2023): advanced immunopeptidomics for fast & reliable immunogenic profiling
Immunespec uses advanced immunopeptidomics for fast & reliable immunogenic profiling. Thanks to this renewed approach to unlock immunogenic regions of proteins they contribute to the development of safe, effective vccines and therapeutics.
Football college (2022): research on good governance of football and practical education
Football College conducts and disseminates research on good governance of football. It offers educational programmes and events that are both academically underpinned and practically oriented, in addition to ad hoc advice.
IoSA (2022): animal behavior monitoring tool
IoSA combines the expertise of engineers of imec-IDlab and ecologists of UAntwerp to create logging tools, focusing on highly accurate proximity tracking and ultra-low power data processing. While traditional trackers are rather bulky and heavy, IoSA was able to pack these features in ultra-light miniaturized solutions, weighing no more than 5 percent of the animal’s body weight. IoSA’s solutions will provide new valuable insights to researchers, wildlife and conservation organizations, zoos, and farmers on how animals interact and move.
Optanic (2022): plasma technology for dry reforming of methane into syngas and methanol
Optanic aims to to scale up plasma technology for dry reforming of methane into syngas and methanol, and build larger (atmospheric pressure glow discharge) plasma reactors, of interest for biogas valorization, and producing value-added chemicals from it
Innocens (2022): AI based Clinical Decision Support System for Neonatal Intensive Care
Innocens is a spin-off company from the University Hospital Antwerp/University Antwerp founded. Their vision is to improve care by providing healthcare workers explainable insights on their growing landscape of available clinical data. Innocens developed an AI based Clinical Decision Support System for Neonatal Intensive Care that keeps the healtcare worker in the lead of her/his decision. The digital health worker provides a 24/7 risk prediction and explains its reasoning. The technology is privacy compliant and scalable to different intensive care settings. Innocens technology improves your clinical insights and enriches your data to create a continuous improving environment. The vision of Innocens is to aid decision-making of healthcare workers taking care of vulnerable infants. Together we create value to what all of us consider most valuable in our life!
ImmuneWatch (2021): Determines the target of T-cell receptors
Immunewatch is a Belgium based spin-off of the University of Antwerp and the Antwerp University Hospital, aiming to accelerate the development of vaccines and therapies by making immune repertoire data interpretable and clinically actionable. Using bio-informatics and artificial intelligence, Immunewatch determines the target of T-cell receptors (TCR), leading to improved prediction and monitoring of the immune response. By sequencing and analyzing the TCR repertoire, the team provides their customers with a better understanding of T-cell responses in the fields of infectious diseases, oncology and auto-immunity.
Garvis (2021): Bionic AI planning platform
Garvis is a bionic forecasting solution that combines transparent artificial intelligence with the insights of the planner for real-time data analysis. This allows to reduce the forecast error with 30% and allows enterprises to provide a better service with less time and less stock. Garvis has a big impact on the bottom line of an enterprise and can be implemented in less than 24 hours.
Deltaray (2019): 3D Xray-technologie
Deltaray BV is a new class leader in the market of Quality 4.0 inspection for critical parts production. They offer a 3D X-RAY breakthrough technology that provides uncompromised defect-detection at the precision and speed desired by producers.
Shavatar (2019): Technology generates 3D body shape
Shavatar’s technology generates your 3D body shape with an average accuracy of 7mm without the need for a scanner. The model is being applied to provide size & fit recommendations while shopping online for clothing, reducing the number of returns and improving the online shopping experience.
iFlux (2017): Measurements soil contamination
Complex soil contamination is often accompanied by an endless and expensive remediation process, caused by the uncertainty about how it is actually spreading below ground. Our technology measures the speed and direction of contaminant spreading underground over a certain period.
Froomle (2016): Software based on data science
Froomle believes user experiences should be much smarter and more relevant than they are today. Froomle's machine learning software enables consumer-facing companies to make their user experiences smart and relevant based on historical interaction data.
BrightSpec NV/SA (2012): Nuclear and X-ray instrumentation
Combines vast technical experience in the field of radiation detection and engineering with widespread proficiency in sales and marketing of nuclear and X-ray instrumentation. Furthermore, the group possesses a good knowledge of modern programming techniques, programming structures and algorithms, databases and data communications, computer and IT technologies.
icoMetrix (2011): Imaging Techniques and analysis methods
icoMetrix offers advanced image processing needed for the quantitative analysis of biomedical images.
HI10 Security Integrations (2010): Data security and cloud systems architecture
Data security, cloud systems' architecture, security and efficiency by delivering optimal solutions: integration digital signatures, cloud security projects, BC / DR plans.
Mu Technologies (2007): Sound modeling and analysis
Develops and distributes innovative software and hardware applications and technology for analysis, modeling, and synthesis of sound waves.
Status: exit
Meshbone (2009): Wireless networking technology
Meshbone, formerly Wishbone, delivers user-friendly, robust and secure wireless mesh network solutions providing a communications infrastructure in buildings, campuses and "event areas" without any kind of cabling.
DCI Labs (2001): High Content Screening
Develops software and services for 'high content screening' and cellular assays based on state of the art imaging techniques.
Tech Transfer
The Tech Transfer Office (TTO) provides the link between academia and industry. Their service facilitates the transfer of the unique knowledge and innovative technologies developed at Antwerp University Association (AUHA) institutions to the business sector.